🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
FAQ|Rules|Members
Log In Register
Forums›MASH / Liver Disease

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards

MASH / Liver Disease

45 threads · 678 posts
MS
Study Survodutide MASH Phase 2b — histological improvement data
MASHdoc_SA · Today at 7:50 AM
9Replies
117Views
MS
MASHdoc_SA
Today at 7:50 AM
MS
Study Semaglutide and MASH — liver fat reduction quantification
MASHdoc_SA · Today at 6:08 AM
13Replies
146Views
MS
MASHdoc_SA
Today at 6:08 AM
MS
Guide Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-1
MASHdoc_SA · Today at 1:26 AM
10Replies
303Views
MS
MASHdoc_SA
Today at 1:26 AM
B
Study ALT normalization rates on GLP-1 — pooled trial data
BethLabQueen · Yesterday at 5:45 PM
20Replies
530Views
B
BethLabQueen
Yesterday at 5:45 PM
MS
Study GLP-1 hepatoprotection — direct vs indirect mechanisms
MASHdoc_SA · Yesterday at 7:05 AM
16Replies
402Views
MS
MASHdoc_SA
Yesterday at 7:05 AM
MS
Study MASH resolution without worsening fibrosis — endpoint analysis
MASHdoc_SA · Thursday at 5:26 PM
11Replies
281Views
MS
MASHdoc_SA
Thursday at 5:26 PM
MS
Study Liver biopsy changes on semaglutide — 72-week histology data
MASHdoc_SA · Thursday at 12:47 AM
15Replies
325Views
MS
MASHdoc_SA
Thursday at 12:47 AM
B
Hot My fatty liver reversal — FibroScan before and after
BethLabQueen · Wednesday at 5:10 AM
14Replies
284Views
B
BethLabQueen
Wednesday at 5:10 AM

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
D
Guide MASH prevalence in GLP-1 users — screening recommendations
Dr.GastroMayo · Tuesday at 6:33 AM
5Replies
178Views
D
Dr.GastroMayo
Tuesday at 6:33 AM
TM
New Survodutide SYNCHRONIZE Phase 3 — MASH primary endpoint design
TrialTracker_MD · Monday at 4:57 AM
3Replies
228Views
TM
TrialTracker_MD
Monday at 4:57 AM
MS
Study Semaglutide liver fat quantification — MRI-PDFF data from multiple trials
MASHdoc_SA · Sunday at 12:22 AM
22Replies
672Views
MS
MASHdoc_SA
Sunday at 12:22 AM
MS
Study De novo lipogenesis reduction on GLP-1 — mechanistic hepatology
MASHdoc_SA · Mar 6, 2026
17Replies
523Views
MS
MASHdoc_SA
Mar 6, 2026
D
Study Fibrosis regression on GLP-1 — is scarring really reversible?
Dr.PathRoch · Mar 5, 2026
21Replies
557Views
D
Dr.PathRoch
Mar 5, 2026
MS
Guide MASH biomarker panel — OWLiver, NIS4, ELF vs biopsy correlation
MASHdoc_SA · Mar 3, 2026
7Replies
314Views
MS
MASHdoc_SA
Mar 3, 2026
DA
Hot My liver enzyme journey — ALT from 98 to 19 on semaglutide
DerekSJ_a1c · Mar 2, 2026
29Replies
552Views
DA
DerekSJ_a1c
Mar 2, 2026
123…8
Users browsing this forum: Admin, Dr.Martinez, mike_mod, sarah.morrison and 37 guests
CompoundTalk Weekly Digest

Top threads, new research, and vendor alerts every Friday.

ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register